–Joining forces for single-cell research excellence– PLEASANTON, CA.—10x Genomics, Inc., a company focused on accelerating genomic discovery, today announced that it has joined the Corporate Partnership Program of the European Molecular Biology Laboratory (EMBL), one of the world’s leading research institutions. “As a leader in single cell genomics, 10x Genomics is investing in institutional training […]
The Rosalind Franklin Institute, a new national centre for interdisciplinary science, announces its first capital investment today. The namesake of the institute, the pioneering X-ray crystallographer Rosalind Franklin, was one of the key figures in the discovery of the structure of DNA, and used a technique with roots in physics and technology to transform life […]
ATUM licenses Company’s Leap-In Transposase® Technology to Just NEWARK, Calif.–Dedicated to creating technologies and tools to improve peoples’ lives, ATUM today announced a patent licensing agreement giving Just Biotherapeutics access to the company’s Leap-In cell line development tools. “We love everything about Just’s mission, and we are delighted that our Leap-In technology will be used to help democratize access […]
Real Endpoints plays 3rd party role introducing parties, helping craft structure, and will provide all analytics and financial reconciliation SAN DIEGO, WELLESLEY, Mass. and WESTPORT, Conn. — Illumina, Inc. and Harvard Pilgrim Health Care announced on February 1 a major new value-based contract (VBC) – one of the first of its kind between a […]
Fleet to provide support for Gyrolab platform users in developing, transferring and optimizing assays Uppsala, Sweden, and Hampshire, UK: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, and Fleet Bioprocessing Ltd. (Fleet), an expert provider of contract immunoassay development services and immunoassay reagent manufacture, announced today […]
Illumina and Genomics England partnership sequences 50,000 genomes The United Kingdom’s pioneering 100,000 Genomes Project has reached a major milestone by sequencing 50,000 genomes. Of those 50,000 genomes sequenced so far, 8,000 are for cancer patients and 42,000 for rare diseases. Breast, brain, colorectal, lung, prostate and renal are among those cancers to have […]
GenomeNext and Genomenon Partner to Speed Variant Curation for Whole Exome and Whole Genome Analysis ANN ARBOR, MI — GenomeNext, LLC announced today that it has embedded Genomenon’s Mastermind search results in its Olympus Platform to simplify and accelerate variant curation for genomic analysis. Efficacious variant interpretation is a critical but challenging requirement to translate genomics […]
Fully integrated request and task management system simplifies and streamlines biologics R&D workflows and resource planning Basel, Switzerland Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced the successful completion of a collaboration with Boehringer Ingelheim to develop a new Request Management System (RMS) to efficiently manage […]
Metrohm USA is proud to announce the release of a new standard leveraging its Combustion Ion Chromatography (CIC) systems. This new standard, ASTM D8150, provides a test method for the determination of harmful organic chlorides in crude oil. Organic chlorides do not occur naturally in crude oil; they result from operations during the refinery process. […]
Zurich, Switzerland and New Delhi, India ChromaCon and YMC India announced today that they have entered into a Distribution Agreement. Under this agreement, YMC India will act as distributor and provide after-sales service and application support for Contichrom systems in India. The Contichrom line of products consists of FPLC and HPLC systems with advanced process […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
